Dealmakers & Disruptors: Medspa M&A in 2026 | Kisaco Research

Top insiders reveal behind-the-scenes insights on bold mergers, creative alliances, and disruptive MSO strategies. Gain quantifiable metrics from recent deals, practical tips on integration, and proven approaches for building scalable, sustainable value in a consolidating market. 

Session Topics: 
Growth & Expansion
Future Trends & Market Intelligence
Legal & IP
Funding & M&A
Speaker(s): 
Moderator

Author:

Allison Beller

Partner
Prelude Growth Partners

Allison Beller is a partner at Prelude Growth Partners, a New York-based, female-founded consumer growth fund. Prior to joining Prelude, Allison was a Managing Director at Goldman Sachs & Co in the Private Equity group within the Asset Management Division, where she worked for over 18 years. Her investing experience covered the Consumer and Services landscape. Allison began her career at Credit Suisse First Boston in the Financial Sponsors group. Allison received a Bachelors of Science in Finance from The Wharton School of the University of Pennsylvania. 

Allison Beller

Partner
Prelude Growth Partners

Allison Beller is a partner at Prelude Growth Partners, a New York-based, female-founded consumer growth fund. Prior to joining Prelude, Allison was a Managing Director at Goldman Sachs & Co in the Private Equity group within the Asset Management Division, where she worked for over 18 years. Her investing experience covered the Consumer and Services landscape. Allison began her career at Credit Suisse First Boston in the Financial Sponsors group. Allison received a Bachelors of Science in Finance from The Wharton School of the University of Pennsylvania. 

Author:

David Marks

Partner
Holland & Knight

David Marks enjoys closing fast-paced, high-pressure deals by aligning economic interests on both sides of the transaction. His practice focuses on buy-side and sell-side private equity M&A, and he has extensive experience in healthcare and other industries. In recent years, Mr. Marks has played a key role in numerous middle-market healthcare transactions involving dental, dermatology, ophthalmology, optometry and optical, chiropractic and physical therapy, women's health, gastroenterology and other specialties.

Private equity clients, investors and sellers value his counsel in recapitalizations, add-on acquisitions and roll-ups. Additionally, Mr. Marks represents private equity firms, investors and privately held companies in sales of portfolio companies and investments involving PE acquirers. Clients benefit from his ability to bring deals to successful conclusions despite the challenges often posed by the complex financing structures and deadlines of private equity transactions.

Previously, Mr. Marks gained valuable experience as an associate in New York where he advised private equity firms, distressed businesses and major financial institutions in the design and implementation of sweeping operational and financial restructurings and M&A in some of the largest Chapter 11 cases in recent history.

David Marks

Partner
Holland & Knight

David Marks enjoys closing fast-paced, high-pressure deals by aligning economic interests on both sides of the transaction. His practice focuses on buy-side and sell-side private equity M&A, and he has extensive experience in healthcare and other industries. In recent years, Mr. Marks has played a key role in numerous middle-market healthcare transactions involving dental, dermatology, ophthalmology, optometry and optical, chiropractic and physical therapy, women's health, gastroenterology and other specialties.

Private equity clients, investors and sellers value his counsel in recapitalizations, add-on acquisitions and roll-ups. Additionally, Mr. Marks represents private equity firms, investors and privately held companies in sales of portfolio companies and investments involving PE acquirers. Clients benefit from his ability to bring deals to successful conclusions despite the challenges often posed by the complex financing structures and deadlines of private equity transactions.

Previously, Mr. Marks gained valuable experience as an associate in New York where he advised private equity firms, distressed businesses and major financial institutions in the design and implementation of sweeping operational and financial restructurings and M&A in some of the largest Chapter 11 cases in recent history.

Author:

Ben Hernandez

CEO & Managing Director
Skytale Group

Ben Hernandez

CEO & Managing Director
Skytale Group

Author:

John Wheeler

Founder & CEO
Alpha Aesthetics Partners

John Wheeler

Founder & CEO
Alpha Aesthetics Partners

Author:

Sarah Brooks Gabriel

CEO
Beverly Hills Rejuvenation Center

Sarah Brooks Gabriel

CEO
Beverly Hills Rejuvenation Center
Time: 
3:45-4:15pm
Session Type: 
Panel
Force Inline Description: 
0